Agios Pharmaceuticals reported $1.05B in Equity Capital and Reserves for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Agios Pharmaceuticals AGIO:US USD 1.05B 73.9M
Alnylam Pharmaceuticals ALNY:US USD -67638000 243.68M
Amgen AMGN:US USD 3.65B 1.23B
Arrowhead Research ARWR:US USD 398.52M 55.41M
Astellas Pharma 4503:JP JPY 1.65T 110.47B
AstraZeneca AZN:LN USD 35.13B 798M
Bayer BAYN:GR EUR 41.27B 3.25B
Biogen BIIB:US USD 12.78B 903M
Biomarin Pharmaceutical BMRN:US USD 4.57B 63.71M
Bluebird Bio BLUE:US USD 158.86M 21.26M
Bristol Myers Squibb BMY:US USD 32.67B 71M
Daiichi Sankyo 4568:JP JPY 1.47T 66.9B
Eli Lilly And LLY:US USD 10.07B 1.53B
Exelixis EXEL:US USD 2.49B 100.14M
Gilead Sciences GILD:US USD 21.06B 821M
GlaxoSmithKline GSK:LN GBP 9.15B 7.22B
Immunogen IMGN:US USD 178.01M 71.82M
IONIS PHARMACEUT IONS:US USD 594.36M 30.36M
JAZZ PHA JAZZ:US USD 2.75B 455.59M
Mirati Therapeutics MRTX:US USD 1.13B 17.05M
Moderna Inc MRNA:US USD 17.99B 7M
Nektar Therapeutics NKTR:US USD 412.22M 46.51M
Novartis NOVN:VX USD 60.82B 2.1B
Novartis NVS:US USD 60.82B 2.1B
Puma Biotechnology PBYI:US USD 22.15M 2.42M
Regeneron Pharmaceuticals REGN:US USD 21.44B 751M
Roche Holding ROG:VX 25.19B 700M
Sarepta Therapeutics SRPT:US USD 430.84M 295.62M
Seattle Genetics SGEN:US USD 2.82B 111M
Vertex Pharmaceuticals VRTX:US USD 13.03B 1.1B
YTE INCY:US USD 4.23B 141.59M